logo

Diseases and Drugs

Share

coronavirusvaccine march23 While the governments, researchers, companies among others are in search of one or more treatments that can help address the deadly Coronavirus, investors are in search of investment opportunities in biotech and pharmaceutical stocks. The following are some of the companies developing drugs/vaccines for COVID-19.

Diagnostics play a key role in combating a flu pandemic because the test results not only help to know if a person has been infected by the virus but will also help to take measures to prevent the infection spread.

pharma 051117 17mar20 Diagnostics play a key role in combating a flu pandemic because the test results will help to know if a person has been infected by the virus and will also help to take measures to prevent the spread of infections.

disney march16 The World Health Organization, on March 11, 2020, declared COVID-19, caused by SARS-CoV-2 virus, a pandemic due to the alarming levels of spread and severity of the virus.

fda mar02 A medical hot topic that been making headlines this year is the coronavirus outbreak. As per the latest World Health Organization report, 53 countries have been impacted by the new coronavirus COVID-19, with 85,403 confirmed cases globally - a vast majority of them being in China. The number of deaths due to the coronavirus is 2,838 in China and 86 outside of China.

corona feb27 The new coronavirus, COVID-19, which originated in China, has now spread to least 47 countries, infecting over 81,000 people and killing 3,000 people, with the majority of them in China.

who jan31 The World Health Organization has declared the ongoing new coronavirus outbreak a public health emergency of international concern.

cronovirus1 jan28 February is just around the corner. It's that time to take a look back at some of the top news stories of January and look ahead at what's coming next over the horizon on the regulatory front.

collage dec31 A total of 48 novel drugs and biologics received FDA approval in 2019. Let's take a look at the FDA calendar of January 2020.

failure dec17 In this article, we present some of the phase III clinical trial failures that made major news headlines in 2019. These were compounds on which companies had bet big, with patients and the medical community having had high hopes.

sentosa dec02 As we begin the final month of the year, it's time to take a look at the drug candidates lined up at the FDA altar awaiting the federal agency's decision.

stickfigures nov20 It's been more than 4 years since the first biosimilar Zarxio was approved in the U.S. Zarxio, developed by Sandoz, a Novartis division, is a biosimilar version of Amgen Inc.'s (AMGN) Neupogen, and it received the regulatory nod in the U.S. in March 2015.

trikafta oct28 As another month comes to an end, it's time to take a look back at some of the pharma news stories of October and look ahead at what's coming next over the horizon on the regulatory front.

fdaapproval oct04 New drugs approved in September

rybelsus sept27 It has been an eventful September, with a number of notable firsts achieved on the regulatory front. Now, let's take a look at the companies that await a ruling from the FDA in October 2019.

Follow RTT
>